BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2841096)

  • 1. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
    Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
    Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
    Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
    Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
    Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ; Aurbach GD
    Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational requirements for activity of salmon calcitonin.
    Findlay DM; Michelangeli VP; Martin TJ; Orlowski RC; Seyler JK
    Endocrinology; 1985 Sep; 117(3):801-5. PubMed ID: 4017965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
    Nakamuta H; Orlowski RC; Epand RM
    Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of calcitonin gene-related peptide receptors in porcine renal medullary membranes.
    Aiyar N; Nambi P; Griffin E; Bhatnagar P; Feuerstein G
    Endocrinology; 1991 Aug; 129(2):965-9. PubMed ID: 1649752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human placental calcitonin receptors.
    Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Michelangeli VP; Martin TJ
    Biochem J; 1988 Mar; 250(3):877-82. PubMed ID: 2839149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells.
    Schneider HG; Michelangeli VP; Frampton RJ; Grogan JL; Ikeda K; Martin TJ; Findlay DM
    Endocrinology; 1992 Sep; 131(3):1383-9. PubMed ID: 1324161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.
    Nicholson GC; Moseley JM; Yates AJ; Martin TJ
    Endocrinology; 1987 May; 120(5):1902-8. PubMed ID: 3032571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
    Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
    Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of interspecies differences in renal and skeletal receptor binding and adenylate cyclase stimulation with human calcitonin.
    Goltzman D
    Endocrinology; 1980 Feb; 106(2):510-8. PubMed ID: 6243538
    [No Abstract]   [Full Text] [Related]  

  • 15. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat kidney cells in primary culture: interaction of salmon calcitonin with receptor sites.
    Chao WT; Forte LR
    Endocrinology; 1983 Feb; 112(2):745-52. PubMed ID: 6293809
    [No Abstract]   [Full Text] [Related]  

  • 17. Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes.
    Stangl D; Muff R; Schmolck C; Fischer JA
    Endocrinology; 1993 Feb; 132(2):744-50. PubMed ID: 8381072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of functional calcitonin receptors.
    Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Martin TJ
    Biochem J; 1988 Jul; 253(2):505-10. PubMed ID: 2845921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
    Findlay DM; Michelangeli VP; Robinson PJ
    Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
    Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
    Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.